FinTrust Capital Advisors’s Guardant Health GH Stock Holding History

FinTrust Capital Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$276	Hold	12	–	–	﹤0.01%	1332
2024 Q2	$347	Hold	12	–	–	﹤0.01%	1323
2024 Q1	$248	Hold	12	–	–	﹤0.01%	1232
2023 Q4	$325	Hold	12	–	–	﹤0.01%	1206
2023 Q3	$356	Buy	+12	New	+$422	﹤0.01%	1181
2022 Q1	–	Sell	-285	Closed	-$29K	–	1248
2021 Q4	$29K	Sell	285 -298	-51%	-$30.8K	0.01%	646
2021 Q3	$73K	Buy	583 +150	+35%	+$17.8K	0.02%	489
2021 Q2	$54K	Buy	433 +340	+366%	+$45.7K	0.01%	540
2021 Q1	$14K	Buy	93 +6	+7%	+$907	﹤0.01%	805
2020 Q4	$11K	Hold	87	–	–	﹤0.01%	819
2020 Q3	$10	Buy	87 +67	+335%	+$6.13K	﹤0.01%	806
2020 Q2	$2K	Sell	20 -386	-95%	-$31.1K	﹤0.01%	925
2020 Q1	$28K	Buy	406 +386	+1,930%	+$29.6K	0.01%	555
2019 Q4	$2K	Buy	+20	New	+$1.44K	﹤0.01%	990

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FinTrust Capital Advisors's GH Position: Q3 2024 in Review

FinTrust Capital Advisors held its Guardant Health (GH) position steady in Q3 2024 at 12 shares worth $276. The position accounts for ﹤0.01% of the portfolio, ranked #1332.

FinTrust Capital Advisors first reported a position in GH in Q4 2019 and has held it in 14 quarters since. The position peaked at $73K in Q3 2021. 270 funds tracked by Wall St. Rank hold GH as of Q3 2024.

FinTrust Capital Advisors held 12 shares of Guardant Health worth $276 as of Q3 2024.
FinTrust Capital Advisors left its Guardant Health share count unchanged in Q3 2024.
Guardant Health made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1332 holding.
FinTrust Capital Advisors first reported a position in Guardant Health in Q4 2019 and has held it in 14 quarters since.
FinTrust Capital Advisors's Guardant Health position peaked at $73K in Q3 2021.
270 funds tracked by Wall St. Rank held Guardant Health as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.